Group One Trading
VYNT

Group One Trading’s Vyant Bio, Inc. Common Stock VYNT Stock Holding History

Group One Trading’s Portfolio VYNT Stock Details VYNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-7
Closed -$3K – 5079
2015
Q4 		$3K Sell
7
-1
-13% -$723 ﹤0.01% 4494
2015
Q3 		$9K Sell
8
-25
-76% -$38.3K ﹤0.01% 4347
2015
Q2 		$59K Buy
+33
New +$51.3K ﹤0.01% 3443
2015
Q1 		– Sell
-26
Closed -$26K – 5321
2014
Q4 		$26K Sell
26
-83
-76% -$83.2K ﹤0.01% 3813
2014
Q3 		$147K Buy
109
+16
+17% +$22.9K ﹤0.01% 2651
2014
Q2 		$158K Buy
93
+66
+244% +$126K ﹤0.01% 2605
2014
Q1 		$60K Buy
+27
New +$69.1K ﹤0.01% 3491

Other funds holding VYNT

PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
Fairbanks Capital Management Rancho Santa Fe, California $160M AUM 14.36% 1-Year Est. Return
DM
Diker Management New York $112M AUM 59.78% 1-Year Est. Return
FPB
First PREMIER Bank Sioux Falls, South Dakota $619M AUM 20.21% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Group One Trading's VYNT Position: Q1 2019 in Review

Group One Trading sold out of Vyant Bio, Inc. Common Stock (VYNT) in Q1 2019, closing a stake of 1 share.

Group One Trading first reported a position in VYNT in Q2 2014 and held it in 6 quarters. The position peaked at $140K in Q3 2014. 24 funds tracked by Wall St. Rank hold VYNT as of Q1 2019.

  • Group One Trading reported no remaining Vyant Bio, Inc. Common Stock position as of Q1 2019 after selling out during the quarter.
  • Group One Trading sold 1 Vyant Bio, Inc. Common Stock share in Q1 2019.
  • Group One Trading first reported a position in Vyant Bio, Inc. Common Stock in Q2 2014 and held it in 6 quarters.
  • Group One Trading's Vyant Bio, Inc. Common Stock position peaked at $140K in Q3 2014.
  • 24 funds tracked by Wall St. Rank held Vyant Bio, Inc. Common Stock as of Q1 2019.

Based on Group One Trading's 13F filing for Q1 2019, filed 13 May 2019.